Curative therapies are most successful when cancer is diagnosed and treated at an early stage. We advocate that technological advances in next-generation sequencing of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing safe and effective cancer screening tests.
Aravanis, A. M., Lee, M., & Klausner, R. D. (2017, February 9). Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection. Cell. Cell Press. https://doi.org/10.1016/j.cell.2017.01.030